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In most jurisdictions, it is a widely accepted ethical and legal requirement that 
clinicians and researchers must obtain informed consent before conducting a clinical or 
research intervention. Like any other adult person, old and very old people with or without a 
mental disorder have the fundamental right to decide whether to accept proposed medically 
indicated treatment, or to participate in research. However, to exercise this right they must be 
sufficiently informed, have decision-making capacity, and exhibit voluntariness in reaching a 
decision (Beauchamp, 2011). 
Many questions concerning the informed consent process, and the possibility to plan 
medical treatments or participate in clinical research in advance, must be resolved to enable 
people to prepare for the risk of substantially impaired decision-making capacity in the future. 
How should decision-making capacity be assessed in clinical and research practice? How can 
clinicians or researchers deal with persons who lack decision-making capacity in a way that is 
compatible with attaching importance to autonomy, while taking into consideration 
continuously developing international, and national laws and their challenging practical 
implementations (e.g., UN-Convention on the Rights of Persons with Disabilities (CRPD); the 
fourth amendment of the German Medicinal Products Act (AMG))? In current national and 
international debates, the opportunities provided by advance directives, and the means for 
their improvement through the likes of advance care planning and research planning, are of 
crucial significance.  
There is no doubt that such debates should be multi- and interdisciplinary and take 
advantage of scientific and practical expertise. Improvements in the informed consent process 
and advance planning will particularly benefit geriatric patients because of the high 
prevalence of both cognitive deficits and (chronic) illnesses, and the frequent need for 
treatment decisions, in this group of patients. . 
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This special issue aims to contribute to multi- and interdisciplinary, scientific and 
practical debates on informed consent and advance planning. The emphasis lies on challenges 
in the assessment of decision-making capacity in clinical practice, and on the chances and 
difficulties of advance planning of research and treatment decisions. The four contributions 
include conceptual, quantitative and qualitative empirical papers. 
The first contribution in this issue presents findings from a survey study on 
knowledge, attitudes, and the evaluation of decision-making capacity among general 
practitioners and psychiatrists in Croatia. Novosel, Marušić, Biller-Andorno, and Trachsel 
report that almost all participants indicated they would welcome official guidelines and 
training because of perceived qualification deficits. The results are similar to outcomes from 
studies conducted in various other countries and may influence future policy-making 
processes. 
In the second contribution, Iseli, Wangmo, Hermann, Trachsel, and Elger present a 
qualitative approach to analyzing semi-structured interviews with healthcare professionals 
from Switzerland. The authors found that three factors made the evaluation of decision-
making capacity difficult for clinicians in their daily work: patient characteristics, differing 
opinions and the consequences of decision-making capacity evaluations, and familial and 
legal issues affecting the evaluation process.  
The third contribution studies decision-making capacity and advance research 
directives from a conceptual point of view. Against the background of the international legal 
and ethical framework for biomedical research and particularly the fourth amendment of the 
German Medicinal Products Act (AMG), Scholten, Gieselmann, Gather, and Vollmann 
explore the implementation of advance research directives in the context of non-therapeutic 
research in incompetent populations.  
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The contribution of Wicki in this issue focuses on decision-making capacity in 
advance care planning for people with intellectual disabilities. The author provides and tests a 
new instrument for the evaluation of decision-making capacity in persons with intellectual 
disabilities - an important and timely contribution in a widely neglected area of research.  
The final section of this special issue combines the results of the four multi- and 
interdisciplinary contributions and draws the conclusion that the normative and empirical 
sciences should focus more strongly on providing practitioners with the chance to follow and 
contribute to further developments in the dynamically changing national, and international 
regulatory environment. There is plenty of work to do before advances in normative 
conceptualizations find their way into sound empirical studies and implementation concepts 
and ultimately into clinical, and research practice.  
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